Europlasma S.A. buy krebskrebs
Start price
25.01.21
/
50%
€18,400
Target price
25.01.22
€100,000
Performance (%)
-94.46%
End price
26.01.22
€1,020.0
Summary
This prediction ended on 26.01.22 with a price of €1,020.0. The BUY prediction by krebskrebs for Europlasma S.A. performed very badly with a performance of -94.46%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Europlasma S.A. | - | - | - | - |
iShares Core DAX® | 1.887% | 1.967% | 17.000% | 18.227% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% | 35.321% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% | -0.898% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% | 39.161% |
Comments by krebskrebs for this prediction
In the thread Europlasma S.A. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Europlasma S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten